APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atovaquone and Proguanil

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Atovaquone and Proguanil Market Outlook and Growth Opportunities 2026

20 December 2025195 pages

Choose your research edition.

Industry ResearchAtovaquone and Proguanil Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Atovaquone and Proguanil Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Atovaquone and Proguanil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atovaquone and Proguanil Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Atovaquone and Proguanil Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Atovaquone and Proguanil market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Atovaquone and Proguanil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Atovaquone and Proguanil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Atovaquone and Proguanil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Atovaquone and Proguanil market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Atovaquone and Proguanil market include GSK, Mylan Pharmaceuticals, Hetero and Glenmark, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Atovaquone and Proguanil market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Atovaquone and Proguanil and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Atovaquone and Proguanil sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Atovaquone and Proguanil market size, projected growth trends, production technologies, key applications, and end-use industries.

Atovaquone and Proguanil Segment by Company

GSK

Mylan Pharmaceuticals

Hetero

Glenmark

Atovaquone and Proguanil Segment by Type

250 mg/100 mg

62.5mg/25mg

Atovaquone and Proguanil Segment by Application

Adult

Paediatric

Atovaquone and Proguanil Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Atovaquone and Proguanil status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Atovaquone and Proguanil market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Atovaquone and Proguanil significant trends, drivers, influence factors in global and regions.

6. To analyze Atovaquone and Proguanil competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atovaquone and Proguanil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atovaquone and Proguanil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atovaquone and Proguanil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Atovaquone and Proguanil market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Atovaquone and Proguanil industry.

Chapter 3: Detailed analysis of Atovaquone and Proguanil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Atovaquone and Proguanil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Atovaquone and Proguanil in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Atovaquone and Proguanil Industry Trends Table 2. Atovaquone and Proguanil Industry Drivers Table 3. Atovaquone and Proguanil Industry Opportunities and Challenges Table 4. Atovaquone and Proguanil Industry Restraints Table 5. Global Atovaquone and Proguanil Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Atovaquone and Proguanil Revenue Share by Company (2021-2026) Table 7. Global Atovaquone and Proguanil Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Atovaquone and Proguanil Sales Volume Share by Company (2021-2026) Table 9. Global Atovaquone and Proguanil Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Atovaquone and Proguanil Company Ranking, (2024-2026) & (USD Million) Table 11. Global Atovaquone and Proguanil Key Company Manufacturing Base & Headquarters Table 12. Global Atovaquone and Proguanil Company, Product Type & Application Table 13. Global Atovaquone and Proguanil Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Atovaquone and Proguanil by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 250 mg/100 mg Table 18. Significant Companies of 62.5mg/25mg Table 19. Global Atovaquone and Proguanil Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Atovaquone and Proguanil Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Atovaquone and Proguanil Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Atovaquone and Proguanil Sales Volume Share by Type (2021-2026) Table 23. Global Atovaquone and Proguanil Sales Volume Share by Type (2027-2032) Table 24. Global Atovaquone and Proguanil Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Atovaquone and Proguanil Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Atovaquone and Proguanil Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Atovaquone and Proguanil Sales Value Share by Type (2021-2026) Table 28. Global Atovaquone and Proguanil Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Adult Table 30. Significant Companies of Paediatric Table 31. Global Atovaquone and Proguanil Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Atovaquone and Proguanil Sales Volume by Application (2021-2026) & (W Units) Table 33. Global Atovaquone and Proguanil Sales Volume by Application (2027-2032) & (W Units) Table 34. Global Atovaquone and Proguanil Sales Volume Share by Application (2021-2026) Table 35. Global Atovaquone and Proguanil Sales Volume Share by Application (2027-2032) Table 36. Global Atovaquone and Proguanil Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Atovaquone and Proguanil Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Atovaquone and Proguanil Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Atovaquone and Proguanil Sales Value Share by Application (2021-2026) Table 40. Global Atovaquone and Proguanil Sales Value Share by Application (2027-2032) Table 41. Global Atovaquone and Proguanil Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Atovaquone and Proguanil Sales by Region (2021-2026) & (W Units) Table 43. Global Atovaquone and Proguanil Sales Market Share by Region (2021-2026) Table 44. Global Atovaquone and Proguanil Sales by Region (2027-2032) & (W Units) Table 45. Global Atovaquone and Proguanil Sales Market Share by Region (2027-2032) Table 46. Global Atovaquone and Proguanil Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Atovaquone and Proguanil Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Atovaquone and Proguanil Sales Value Share by Region (2021-2026) Table 49. Global Atovaquone and Proguanil Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Atovaquone and Proguanil Sales Value Share by Region (2027-2032) Table 51. Global Atovaquone and Proguanil Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Atovaquone and Proguanil Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Atovaquone and Proguanil Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Global Atovaquone and Proguanil Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Atovaquone and Proguanil Sales by Country (2021-2026) & (W Units) Table 56. Global Atovaquone and Proguanil Sales Market Share by Country (2021-2026) Table 57. Global Atovaquone and Proguanil Sales by Country (2027-2032) & (W Units) Table 58. Global Atovaquone and Proguanil Sales Market Share by Country (2027-2032) Table 59. Global Atovaquone and Proguanil Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Atovaquone and Proguanil Sales Value Market Share by Country (2021-2026) Table 61. Global Atovaquone and Proguanil Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Atovaquone and Proguanil Sales Value Market Share by Country (2027-2032) Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Atovaquone and Proguanil Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. GSK Atovaquone and Proguanil Product Portfolio Table 67. GSK Recent Development Table 68. Mylan Pharmaceuticals Company Information Table 69. Mylan Pharmaceuticals Business Overview Table 70. Mylan Pharmaceuticals Atovaquone and Proguanil Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Mylan Pharmaceuticals Atovaquone and Proguanil Product Portfolio Table 72. Mylan Pharmaceuticals Recent Development Table 73. Hetero Company Information Table 74. Hetero Business Overview Table 75. Hetero Atovaquone and Proguanil Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hetero Atovaquone and Proguanil Product Portfolio Table 77. Hetero Recent Development Table 78. Glenmark Company Information Table 79. Glenmark Business Overview Table 80. Glenmark Atovaquone and Proguanil Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Glenmark Atovaquone and Proguanil Product Portfolio Table 82. Glenmark Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. Atovaquone and Proguanil Distributors List Table 86. Atovaquone and Proguanil Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Atovaquone and Proguanil Product Image Figure 2. Global Atovaquone and Proguanil Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atovaquone and Proguanil Sales Value (2021-2032) & (US$ Million) Figure 4. Global Atovaquone and Proguanil Sales (2021-2032) & (W Units) Figure 5. Global Atovaquone and Proguanil Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Atovaquone and Proguanil Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 250 mg/100 mg Image Figure 10. 62.5mg/25mg Image Figure 11. Global Atovaquone and Proguanil Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Atovaquone and Proguanil Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Atovaquone and Proguanil Sales Volume Share by Type (2021-2032) Figure 14. Global Atovaquone and Proguanil Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Atovaquone and Proguanil Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Atovaquone and Proguanil Sales Value Share by Type (2021-2032) Figure 17. Adult Image Figure 18. Paediatric Image Figure 19. Global Atovaquone and Proguanil Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Atovaquone and Proguanil Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Atovaquone and Proguanil Sales Volume Share by Application (2021-2032) Figure 22. Global Atovaquone and Proguanil Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Atovaquone and Proguanil Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Atovaquone and Proguanil Sales Value Share by Application (2021-2032) Figure 25. Global Atovaquone and Proguanil Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 26. Global Atovaquone and Proguanil Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Atovaquone and Proguanil Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Atovaquone and Proguanil Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Atovaquone and Proguanil Sales Value (2021-2032) & (US$ Million) Figure 30. North America Atovaquone and Proguanil Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Atovaquone and Proguanil Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Atovaquone and Proguanil Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Atovaquone and Proguanil Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Atovaquone and Proguanil Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Atovaquone and Proguanil Sales Value (2021-2032) & (US$ Million) Figure 36. South America Atovaquone and Proguanil Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Atovaquone and Proguanil Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Atovaquone and Proguanil Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Atovaquone and Proguanil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Atovaquone and Proguanil Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Atovaquone and Proguanil Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 250 mg/100 mg
  • 62.5mg/25mg
Applications
  • Adult
  • Paediatric
Companies covered
  • GSK
  • Mylan Pharmaceuticals
  • Hetero
  • Glenmark

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Atovaquone and Proguanil Sales Value (2021-2032)
  4. 1.2.2 Global Atovaquone and Proguanil Sales Volume (2021-2032)
  5. 1.2.3 Global Atovaquone and Proguanil Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Atovaquone and Proguanil Market Dynamics
  1. 2.1 Atovaquone and Proguanil Industry Trends
  2. 2.2 Atovaquone and Proguanil Industry Drivers
  3. 2.3 Atovaquone and Proguanil Industry Opportunities and Challenges
  4. 2.4 Atovaquone and Proguanil Industry Restraints
3 Atovaquone and Proguanil Market by Company
  1. 3.1 Global Atovaquone and Proguanil Company Revenue Ranking in 2025
  2. 3.2 Global Atovaquone and Proguanil Revenue by Company (2021-2026)
  3. 3.3 Global Atovaquone and Proguanil Sales Volume by Company (2021-2026)
  4. 3.4 Global Atovaquone and Proguanil Average Price by Company (2021-2026)
  5. 3.5 Global Atovaquone and Proguanil Company Ranking (2024-2026)
  6. 3.6 Global Atovaquone and Proguanil Company Manufacturing Base and Headquarters
  7. 3.7 Global Atovaquone and Proguanil Company Product Type and Application
  8. 3.8 Global Atovaquone and Proguanil Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Atovaquone and Proguanil Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Atovaquone and Proguanil Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Atovaquone and Proguanil Market by Type
  1. 4.1 Atovaquone and Proguanil Type Introduction
  2. 4.1.1 250 mg/100 mg
  3. 4.1.2 62.5mg/25mg
  4. 4.2 Global Atovaquone and Proguanil Sales Volume by Type
  5. 4.2.1 Global Atovaquone and Proguanil Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Atovaquone and Proguanil Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Atovaquone and Proguanil Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Atovaquone and Proguanil Sales Value by Type
  9. 4.3.1 Global Atovaquone and Proguanil Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Atovaquone and Proguanil Sales Value by Type (2021-2032)
  11. 4.3.3 Global Atovaquone and Proguanil Sales Value Share by Type (2021-2032)
5 Atovaquone and Proguanil Market by Application
  1. 5.1 Atovaquone and Proguanil Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Paediatric
  4. 5.2 Global Atovaquone and Proguanil Sales Volume by Application
  5. 5.2.1 Global Atovaquone and Proguanil Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Atovaquone and Proguanil Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Atovaquone and Proguanil Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Atovaquone and Proguanil Sales Value by Application
  9. 5.3.1 Global Atovaquone and Proguanil Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Atovaquone and Proguanil Sales Value by Application (2021-2032)
  11. 5.3.3 Global Atovaquone and Proguanil Sales Value Share by Application (2021-2032)
6 Atovaquone and Proguanil Regional Sales and Value Analysis
  1. 6.1 Global Atovaquone and Proguanil Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Atovaquone and Proguanil Sales by Region (2021-2032)
  3. 6.2.1 Global Atovaquone and Proguanil Sales by Region: 2021-2026
  4. 6.2.2 Global Atovaquone and Proguanil Sales by Region (2027-2032)
  5. 6.3 Global Atovaquone and Proguanil Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Atovaquone and Proguanil Sales Value by Region (2021-2032)
  7. 6.4.1 Global Atovaquone and Proguanil Sales Value by Region: 2021-2026
  8. 6.4.2 Global Atovaquone and Proguanil Sales Value by Region (2027-2032)
  9. 6.5 Global Atovaquone and Proguanil Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Atovaquone and Proguanil Sales Value (2021-2032)
  12. 6.6.2 North America Atovaquone and Proguanil Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Atovaquone and Proguanil Sales Value (2021-2032)
  15. 6.7.2 Europe Atovaquone and Proguanil Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Atovaquone and Proguanil Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Atovaquone and Proguanil Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Atovaquone and Proguanil Sales Value (2021-2032)
  21. 6.9.2 South America Atovaquone and Proguanil Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Atovaquone and Proguanil Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Atovaquone and Proguanil Sales Value Share by Country, 2025 VS 2032
7 Atovaquone and Proguanil Country-level Sales and Value Analysis
  1. 7.1 Global Atovaquone and Proguanil Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Atovaquone and Proguanil Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Atovaquone and Proguanil Sales by Country (2021-2032)
  4. 7.3.1 Global Atovaquone and Proguanil Sales by Country (2021-2026)
  5. 7.3.2 Global Atovaquone and Proguanil Sales by Country (2027-2032)
  6. 7.4 Global Atovaquone and Proguanil Sales Value by Country (2021-2032)
  7. 7.4.1 Global Atovaquone and Proguanil Sales Value by Country (2021-2026)
  8. 7.4.2 Global Atovaquone and Proguanil Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Atovaquone and Proguanil Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Atovaquone and Proguanil Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Atovaquone and Proguanil Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Atovaquone and Proguanil Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Atovaquone and Proguanil Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Mylan Pharmaceuticals
  8. 8.2.1 Mylan Pharmaceuticals Company Information
  9. 8.2.2 Mylan Pharmaceuticals Business Overview
  10. 8.2.3 Mylan Pharmaceuticals Atovaquone and Proguanil Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Pharmaceuticals Atovaquone and Proguanil Product Portfolio
  12. 8.2.5 Mylan Pharmaceuticals Recent Developments
  13. 8.3 Hetero
  14. 8.3.1 Hetero Company Information
  15. 8.3.2 Hetero Business Overview
  16. 8.3.3 Hetero Atovaquone and Proguanil Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hetero Atovaquone and Proguanil Product Portfolio
  18. 8.3.5 Hetero Recent Developments
  19. 8.4 Glenmark
  20. 8.4.1 Glenmark Company Information
  21. 8.4.2 Glenmark Business Overview
  22. 8.4.3 Glenmark Atovaquone and Proguanil Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Glenmark Atovaquone and Proguanil Product Portfolio
  24. 8.4.5 Glenmark Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Atovaquone and Proguanil Value Chain Analysis
  2. 9.1.1 Atovaquone and Proguanil Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Atovaquone and Proguanil Sales Mode & Process
  6. 9.2 Atovaquone and Proguanil Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Atovaquone and Proguanil Distributors
  9. 9.2.3 Atovaquone and Proguanil Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst